Tumor suppressor miR-133a modulates the prostate cancer epigenome by repressing BAZ2A

Study ID Alternative Stable ID Type
EGAS00001000568 Other

Study Description

Our study revealed a new subgroup of prostate tumors defined by the expression of a novel prognostic marker, BAZ2A, and the first time to show the establishment of CIMP via an microRNA-epigenetic interaction in prostate tumors.

Study Datasets 1 dataset.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
DNA methylation analysis of 35 prostate tumor and 6 normal prostate samples

Who archives the data?

There are no publications available